SQM (SQM) Q2 2025: Iodine Gross Margin Hits 57%, Outshining Lithium Volatility

2025-08-20 | By EarningsIQ Research

Margin strength in iodine propelled SQM through a turbulent lithium market, with diversified business lines cushioning revenue pressure. Recent lithium price recovery and volume growth guidance signal a more constructive second half, while strategic expansion and regulatory milestones remain in focus for long-term positioning.

Summary

• Iodine Profitability Surges: Iodine delivered over half of company gross profit, offsetting lithium headwinds.
• Lithium Market Turns: Recent price bounce and volume guidance point to a stronger H2 for core lithium operations.
• Strategic Expansion Deferred: Major growth projects hinge on regulatory and market clarity, pushing significant capex out to 2030 and beyond.

Performance Analysis

SQM’s Q2 results reflected a sharp divergence between its key business segments. The lithium division saw revenue drop more than 30% year-on-year, as contract floors and spot price declines weighed on both realized prices and volumes. However, management flagged a notable shift in market dynamics late in the quarter, with Chinese lithium carbonate prices rebounding and demand from electric vehicles (EVs) and battery energy storage (BEST, battery energy storage technology) accelerating, particularly in China and Europe.

Iodine emerged as the company’s profit engine, delivering a 57% adjusted gross margin and contributing more than 50% of total gross profit. Tight global supply and resilient demand, especially from the medical imaging sector (X contrast media), underpinned both pricing and margin strength. The specialty plant nutrition (SPN, value-added fertilizer blends) business remained stable, with firm pricing offsetting lower potassium volumes.

• Segment Resilience: Iodine and SPN stability cushioned overall margin structure against lithium volatility.
• Volume Outlook: Lithium sales volumes from Chile are projected to rise at least 10% year-on-year, with H2 weighted sales and improved pricing visibility.
• Cost Structure: Mount Holland remains in ramp-up, with long-term cost targets aiming for mid-curve positioning in lithium hydroxide production.

The company’s diversified portfolio provided a crucial buffer, allowing SQM to weather lithium’s cyclical downturn while positioning for upside as prices recover. Strategic flexibility in sales channels and contract structures has enabled rapid response to market inflections.

Executive Commentary

Strategic Positioning

1. Iodine as a Defensive Profit Center

Iodine’s margin and profit contribution are at historic highs, driven by supply constraints and robust demand from medical and industrial applications. Management is investing in new capacity (Pampa Blanca, greenfield expansion, seawater pipeline) to ensure SQM remains the primary global supplier. Environmental permitting and long-cycle planning are seen as key bottlenecks for industry supply growth, reinforcing SQM’s competitive moat.

2. Lithium Volume and Price Flex Levers

The lithium business is positioned for a volume rebound in H2, with contract structures closely tracking spot prices, especially in China. Management expects Q3 sales volumes to be at least 10% higher than Q2, and full-year Chilean lithium volumes to rise by at least 10%. The company’s strategy is to operate at full capacity and avoid speculative withholding, enabling rapid capture of price recoveries.

3. Growth Projects Deferred, Regulatory Milestones Ahead

Major expansion decisions, including Mount Holland and Salar Futuro, have been pushed out, with final investment dependent on market conditions and regulatory approvals. The CODELCO partnership for Salar Futuro is on track for agreement by year-end, but material capex will not impact financials until 2030 or later. This staged approach reduces near-term capex risk and aligns expansion with market absorption capacity.

Key Considerations

SQM’s quarter was defined by its ability to offset cyclical lithium weakness with structural iodine strength, while maintaining operational flexibility and capital discipline.

Key Considerations:

• Iodine Supply Leadership: SQM’s multi-pronged capacity expansion and first-mover investments reinforce its position as the global price setter in iodine.
• Lithium Price Sensitivity: Contract exposure is now closely linked to spot indices, especially in China, increasing both upside and downside volatility in realized prices.
• Capex Phasing: Growth capex is mostly backloaded, with only environmental and permitting costs for Salar Futuro impacting near-term cash flow.
• Inventory and Demand Management: Lithium inventory remains “healthy,” supporting planned volume increases without creating overhang risk.
• Regulatory and Community Engagement: Progress with CODELCO and local communities is advancing on schedule, with management optimistic about approvals and long-term project alignment with Chilean stakeholders.

Risks

Persistent lithium price volatility remains the primary risk, with a significant portion of global supply still underwater at current prices. Regulatory delays, especially in Chile, could defer key projects and create capex uncertainty. Environmental permitting and community relations are critical, as any misstep could impact supply growth and long-term license to operate. The rapid contract reset to spot pricing increases earnings sensitivity to short-term market swings.

Forward Outlook

For Q3 2025, SQM guided to:

• At least 10% higher lithium sales volumes versus Q2, with pricing expected to improve sequentially.
• Iodine segment expected to maintain strong margins and stable demand.

For full-year 2025, management maintained volume growth guidance:

• Chilean lithium volumes up at least 10% YoY; International Lithium Division targeting 20,000 metric tons LCE.

Management highlighted several factors that will shape results:

• Lithium price recovery in China and ongoing contract indexation to spot market.
• Continued investment in capacity expansions for iodine and plant nutrition, with regulatory milestones for Salar Futuro and CODELCO JV due by year-end.

Takeaways

SQM’s diversified model delivered stability in a turbulent quarter, with iodine profitability counterbalancing lithium cyclicality. Investors should focus on the company’s ability to execute on volume growth, maintain cost competitiveness, and advance regulatory milestones for future expansion.

• Iodine’s outsized contribution highlights the value of portfolio diversification, especially in commodity cycles.
• Lithium’s near-term outlook is improving, but remains highly sensitive to spot market swings and contract resets.
• Future performance hinges on regulatory progress and disciplined capex phasing, with major growth optionality deferred to the next decade.

Conclusion

SQM’s Q2 2025 results underscore the importance of margin resilience and portfolio flexibility in volatile markets. While lithium remains the long-term growth engine, iodine’s structural profitability and disciplined expansion planning provide crucial ballast as the company navigates market and regulatory inflection points.

Industry Read-Through

SQM’s results reinforce the bifurcation within the specialty chemicals sector, where diversified producers with exposure to high-margin, supply-constrained segments (like iodine) can outperform pure-play lithium peers during downturns. The rapid contract repricing to spot indices in lithium is a warning for the industry, increasing earnings volatility and exposing weaker producers to price shocks. Regulatory timelines and environmental bottlenecks are emerging as the primary gating factors for new supply, a dynamic likely to constrain global lithium and iodine capacity additions for years to come. Investors should monitor capex discipline, contract structures, and regulatory progress as key performance differentiators across the sector.

SQM Materials Chemicals Lithium Iodine Capex Commodity Regulation